Scrip
US FDA approves Novo Nordisk's Victoza for type II diabetes
26 January 2010
Asher Mullard
Please Login to read the full article.
26 January 2010
Asher Mullard
The US FDA has after some delay approved Novo Nordisk's Victoza (liraglutide) for the treatment of type 2 diabetes in adults. It did not, however, approve the drug for first-line usage, and has placed a "black box" warning on its label about the risk of thyroid tumours.
Novo Nordisk...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- GE Healthcare aims to end unpredictability in early drug research
- Face-to-Face: Trophos - The French firm that hooked Actelion
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
